Co-Diagnostics, Inc. (CODX): הכנסות חזויות של החברה

The future sales revenue chart for Co-Diagnostics, Inc. (CODX) is based on recurring payments for the CoPrimer PCR platform, ensuring a stable cash flow, where the value 0.00 represents the current amount. Operational resilience is supported by external logistics outsourcing, while scaling potential is linked to the launch of the Co-Dx PCR Home system and expansion into emerging markets.

This indicator reflects the company's expected revenue, serving as the basis for calculating forward valuation multiples. The metric synthesizes financial reporting data and market expectations, reacting to any changes in product adoption rates. By analyzing the projected future sales figure, an investor determines the asset's potential for capitalization growth. For Co-Diagnostics, Inc. (CODX), the curve's dynamics reflect the success of the transition to new diagnostic solutions. The updating of the Co-Primers test line for the agricultural and medical sectors directly determines the trajectory of this value.